Maebius, Stephen B.

Your profile? Update now
Updated 10/12/2009

firm image

Foley & Lardner LLP

3000 K Street, N.W.
Suite 600

Washington, DC 20007

Phone: (202) 672-5569

Fax: (202) 672-5399

Contact Us

Websites associated with this firm:http://www.foley.com

Summary

Current Employment Position(s)

Partner

Lawyer Overview

Stephen B. Maebius is an Intellectual Property law partner with Foley & Lardner LLP. He is a member of the firm's Management Committee, chair of the Intellectual Property Department, and co-chair of the Life Sciences Industry Team. He is also a member of the Nanotechnology Industry Team. Prior to becoming a lawyer, he was a patent examiner in the U.S. Patent & Trademark Office in the Biotechnology Group. He now handles many types of IP work for his clients, including IP diligence reviews, opinions, international portfolio management, licensing, litigation, reexaminations, patent term extensions and interferences.

Mr. Maebius has been active as both a teacher and author in the intellectual property field. He has been a visiting associate professor of intellectual property law at Tokyo University's Research Center for Advanced Science and Technology, as well as a faculty adjunct professor at George Washington University Law School, where he taught comparative and international patent law. Mr. Maebius regularly operates in Japan, working with the firm's Tokyo office. In addition, he testified at the 2002 FTC/DOJ hearings on the "Implications of Competition and Patent Law and Policy."

In the area of nanotechnology, Mr. Maebius helped start the NanoBusiness Alliance and the Nanotechnology Law & Business journal. He continues to serve on the advisory board of the NanoBusiness Alliance, and he is an editor-in-chief of the Nanotechnology Law & Business journal.

Mr. Maebius has also been selected by his peers for inclusion in The Best Lawyers in America in the area of Biotechnology law (2007-2010), as well as Intellectual Property (2009-2010). In 2006, he was runner-up in the Washington Business Journal's Top Washington Lawyers for Intellectual Property.

Mr. Maebius graduated from Cornell University (B.S. biology, 1989) and the George Washington University Law School (J.D., 1994). He is admitted to practice in the District of Columbia, the state of Virginia, before the Court of Appeals for the Federal Circuit, the U.S. Supreme Court and before the U.S. Patent and Trademark Office.

He also serves as a board member of the CARES Foundation.

Representative Matters:

  • Takeda Pharmaceutical Co. Ltd. v. John Doll (Fed. Cir. 2009) precedential 2-1 decision remanding a double patenting rejection arising from patent reexamination (remand still pending) 
  • Goldenberg & Immunomedics v. Cytogen & C.R. Bard (Fed. Cir. 2004) - obtained reversal of summary judgment in client's favor in precedential 2-1 decision 
  • Reexamination of 2 patents in parallel litigation covering pharmaceutical with $1.5B in sales per year - obtained decision upholding patentability of all claims in under a year
  • Licensing of biotechnology drug with up-front payment of $100M - represented acquiring company in IP diligence and drafting transaction agreements
  • Publications:

  • "Top Ten Mistakes Made In Inter Partes Reexamination," BNA Patent, Trademark & Copyright Journal, 77 PTCJ 428, 2009 (co-author)
  • "Patenting Risk Evaluation & Mitigation Strategies for Pharmaceuticals: A New Life Cycle Management Target for Patents?" Pharmaceutical Law & Industry, 7(1): 1-3, 2009 (co-author)
  • "The Surprising Efficacy of Inter Partes Reexamination," Patent Strategy & Management, 2008 (co-author)
  • "Bayer Highlights Debate on Research Method Use (Patent Won't Cover Fruit of Offshore Research Not Made with the Method)," National Law Journal, 2001 (co-author)
  • "Extending Process Claims From Intermediate to Final Product: Avoiding the Trap of Eli Lilly v. American Cyanamid," Journal of the Patent & Trademark Office Society, 1998
  • "Novel DNA Sequences and the Utility Requirement: The Human Genome Initiative," Journal of the Patent & Trademark Office Society, 1992
  • Areas of Practice

    • Biotechnology & Pharmaceutical
    • Private Equity & Venture Capital
    • Emerging Technologies
    • International Business
    • Life Sciences
    • Nanotechnology
    • China

    Qualifications

    Bar Admissions

    • Virginia, 1994
    • District of Columbia
    • U.S. Court of Appeals Federal Circuit
    • U.S. Supreme Court
    • U.S. Patent and Trademark Office

    Honors and Awards

    • The Best Lawyers in America in the area of Biotechnology Law
    • Washington Business Journal's 2006 Top Washington Lawyers for Intellectual Property

    Past Employment Positions

    • George Washington University Law School, Adjunct Professor

    Education

    • George Washington University Law School, Washington, District of Columbia, 1994
      J.D.
    • Cornell University, Ithaca, New York, 1989
      B.S.
      Major: Biology

    Articles

    Published Works

    • "Bayer Highlights Debate on Research Method Use (Patent Won't Cover Fruit of Offshore Research Not Made with the Method)", Natl. Law Journal, 2001
    • "Novel DNA Sequences and the Utility Requirement: The Human Genome Initiative", Journal of the Patent & Trademark Office Society, 1992
    • "The New Use of Fair Use: Accessing Copyrighted Programs Through Reverse Engineering", Journal of the Patent & Trademark Office Society, 1993

    Office Information

    Address

    3000 K Street, N.W.
    Suite 600
    Washington, DC 20007

    Phones

    (202) 672-5569

    Faxes

    (202) 672-5399

    Emails

    Contact Us

    Websites

    http://www.foley.com

    When viewing a listing, consider the state advertising restrictions to which lawyers and law firms must adhere, as well as our West Legal Directory disclaimers.